Triple
T6162586
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ministry of Health and Family Welfare (India) |
E137475
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
Central Drugs Standard Control Organisation
The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
|
E574393
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Central Drugs Standard Control Organisation | Statement: [Ministry of Health and Family Welfare (India), oversees, Central Drugs Standard Control Organisation]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Central Drugs Standard Control Organisation Context triple: [Ministry of Health and Family Welfare (India), oversees, Central Drugs Standard Control Organisation]
-
A.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
-
B.
Bureau of Drug Abuse Control
The Bureau of Drug Abuse Control was a U.S. federal agency in the 1960s responsible for enforcing laws against the illegal use and distribution of certain drugs, later merged into the Bureau of Narcotics and Dangerous Drugs.
-
C.
STC on Health, Population and Drug Control
The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
-
D.
Commission on Narcotic Drugs
The Commission on Narcotic Drugs is a United Nations policy-making body responsible for overseeing international drug control and shaping global strategies to address narcotic drugs and related issues.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Central Drugs Standard Control Organisation Triple: [Ministry of Health and Family Welfare (India), oversees, Central Drugs Standard Control Organisation]
Generated description
The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Central Drugs Standard Control Organisation Target entity description: The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
-
A.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
-
B.
Bureau of Drug Abuse Control
The Bureau of Drug Abuse Control was a U.S. federal agency in the 1960s responsible for enforcing laws against the illegal use and distribution of certain drugs, later merged into the Bureau of Narcotics and Dangerous Drugs.
-
C.
STC on Health, Population and Drug Control
The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
-
D.
Commission on Narcotic Drugs
The Commission on Narcotic Drugs is a United Nations policy-making body responsible for overseeing international drug control and shaping global strategies to address narcotic drugs and related issues.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c008a54fc88190b6ce4416490ca79d |
completed | March 22, 2026, 3:20 p.m. |
| NER | Named-entity recognition | batch_69c05d5e8edc8190a7a394ee832bac9f |
completed | March 22, 2026, 9:21 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c14199f024819089af02b1c0eebfad |
completed | March 23, 2026, 1:35 p.m. |
| NEDg | Description generation | batch_69c1467ef4d48190b714823935318c0a |
completed | March 23, 2026, 1:56 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69c146f59d9881908fdc6c0137f0ead7 |
completed | March 23, 2026, 1:58 p.m. |
Created at: March 22, 2026, 4:17 p.m.